XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Sales, net $ 10,445,733 $ 6,029,364 $ 18,740,906 $ 13,628,727
Cost of sales:        
Total cost of sales 10,552,823 6,449,288 18,849,907 12,147,722
Gross profit (loss) (107,090) (419,924) (109,001) 1,481,005
Operating expenses:        
Sales and marketing 1,661,743 1,474,600 3,263,551 2,909,342
Research and development 160,049 199,093 351,241 341,355
General and administrative 3,201,955 3,669,189 6,083,798 6,979,251
Total operating expenses 5,023,747 5,342,882 9,698,590 10,229,948
Loss from operations (5,130,837) (5,762,806) (9,807,591) (8,748,943)
Other income - TIA 1,471,235 1,475,075 2,954,054 2,959,695
Unrealized losses on debt and equity securities 1,555,676 (1,779,814) (5,600,837) (47,165)
Litigation proceeds 1,900,000   1,900,000  
Interest and other income 140,526 244,518 299,472 561,839
Interest expense (22,257) (31,817) (45,710) (65,300)
Loss before income taxes (85,657) (5,854,844) (10,300,612) (5,339,874)
Provision for income taxes 1,814 8,309,796 287,575 8,395,382
Net loss (87,471) (14,164,640) (10,588,187) (13,735,256)
Preferred Stock dividend requirements (57,611) (57,611) (115,222) (115,222)
Net loss applicable to common shareholders $ (145,082) $ (14,222,251) $ (10,703,409) $ (13,850,478)
Basic loss per share $ 0 $ (0.48) $ (0.36) $ (0.46)
Diluted loss per share $ 0 $ (0.48) $ (0.36) $ (0.46)
Weighted average common shares outstanding:        
Basic (in shares) 29,937,159 29,937,159 29,937,159 29,937,159
Diluted (in shares) 29,937,159 29,937,159 29,937,159 29,937,159
Cost of manufactured product        
Cost of sales:        
Total cost of sales $ 9,721,614 $ 5,853,085 $ 17,312,277 $ 10,902,131
Royalty expense to shareholder        
Cost of sales:        
Total cost of sales $ 831,209 $ 596,203 $ 1,537,630 $ 1,245,591